InvestorsHub Logo
Followers 53
Posts 1782
Boards Moderated 0
Alias Born 03/22/2015

Re: The ELTP King post# 295129

Saturday, 07/21/2018 11:42:03 AM

Saturday, July 21, 2018 11:42:03 AM

Post# of 402218

10? 20? 30? WeeZuhl would be the one to ask to get the best answer for this topic.







I also got a few PM's re: this issue of how many competitors for generic Percocet. Unfortunately, it is impossible for me to answer this question. The reason is because it would require me to give a crap, which I don't. Just start making that shit and sell it cheap. Generic success is all about price. The lower the price, the more clicks by pharmacy buyers.


Percocet approval marks an important transition for Elite. There are many competitors for Percocet because it is a big-selling drug. All of ELTP's currently-approved ANDA's are niche products with only a few competitors. Hopefully, there will be a handful more big drug ANDA approvals to follow in the next few years, but currently, they have nothing else like it in the portfolio. So, Percocet is an important test for Nasrat and team. They have our factory ready. They have our first big drug approval. Now what can they do?


How many competitors? Don't care. How competitive? That's the question.





Call on God but row away from the rocks.

-Hunter S. Thompson

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News